Theratechnologies

Quarterly Financials

Values in thousands 2025-05-31 2025-02-28 2024-11-30 2024-08-31
Revenue
$17,729
$19,047
$25,002
$22,600
Gross Profit
13,030
15,564
18,906
18,079
EBITDA
-2,636
2,040
-3,974
6,618
EBIT
-3,109
1,549
-4,467
6,213
Net Income
-4,462
117
-7,903
3,091
Net Change In Cash
17,729
19,047
25,002
22,600
Free Cash Flow
12,395
-19,848
-227
4,604
Cash
9,459
3,905
5,899
34,690
Basic Shares
49,361
50,400
49,372
49,372

Annual Financials

Values in thousands 2024-11-30 2023-11-30 2022-11-30 2021-11-30
Revenue
$85,866
$81,764
$80,057
$69,823
Gross Profit
65,418
62,129
53,778
46,563
EBITDA
6,879
-8,906
-27,826
-17,250
EBIT
4,118
-12,221
-40,297
-25,998
Net Income
-8,306
-23,957
-47,237
-31,725
Net Change In Cash
85,866
81,764
80,057
69,823
Free Cash Flow
879
-7,496
-15,677
-14,643
Cash
5,899
34,097
23,856
20,399
Basic Shares
49,361
73,084
95,253
92,350

Earnings Calls

Quarter EPS
2025-05-31
-$0.09
2025-02-28
$0.002
2024-11-30
-$0.22
2024-08-31
$0.06